Chicago-area biotech sends 2nd drug to India's regulators; Penny stock player spins out PhIII cancer candidate into new company
Pharmazz is on its way to India’s drug regulator for the second time as its investigational treatment passed muster in a Phase III study in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
